Hebrew University is preparing to establish a center for pharmaceutical research
and treatment of children, the dean of HU’s School of Pharmacy,
Simon Benita announced on Monday.
The pharmacy school, which
is marking its 60th anniversary, will deal with fields that no other
pharmaceutical research institutions works on, Benita said this
“There are very serious diseases that affect children, such as
cystic fibrosis and muscular dystrophy, that have no cure,” he
“People don’t completely understand the importance of special
pharmaceutical treatments for children.”
“Half-a-million dollars have
already been collected towards establishing the center in the pharmacy school’s
Jerusalem Ein Kerem campus.
The dean remarked that there are drugs for
these serious diseases given only by injection into the muscle, but this is
These difficulties could be solved with research invested to
treatment specially for children,” said Benita, who is to be director of the
The Jerusalem center joins three others – in Boston, Britain and
Heidelburg, Germany – that focus on suiting drug formulations to
But the HU center will deal with fields in which these three do
not conduct research, Benita said. These include the study of mostly incurable
genetic diseases; building new models for testing drugs for children on lab
animals, without the currently existing need to conduct clinical trials on
children; and synthesizing new molecules suited for children.
field has especially been overlooked around the world because it is not
financially profitable, Benita said.
The HU center aims to conduct
research in such fields as obesity and hypertension that used to affect only
adults but today have also hit many children.
A unique nanotechnology
laboratory was inaugurated at HU’s Peter Brojde Center, which received a NIS 6
million donation from the Brojde family through the Canadian Friends of the the
Hebrew University (CFHU).
“The new Miniature Integrated Systems
Laboratory will merge the top-down approach of ubiquitous computing with the
bottom-up approach of Nano science and nanotechnology,” a Hebrew University
spokesman said. “The alliance between the bottom-up development of new
micro-sensing/manipulating capabilities with the top-down approach to fuse the
information generated in sensor ensembles and networks is expected to play a
major role in a world striving to optimize the use of its energy resources,
preserve the environment, combat terror and provide medical services to
Anna Brojde and her family, who have donated significantly in the
fields of engineering and computer science, dedicated the facility this
“This marks a new era of innovative research at the Brojde Center,”
said CFHU president and CEO Rami Kleinman, “We thank Anna Brojde and her family
and welcome this pioneering venture which will enhance scientific knowledge and
Stay on top of the news - get the Jerusalem Post headlines direct to your inbox!